Panc02-OVA-Luc

Export PDF

Strain Information

Validation Data

Ⅰ.In vitro Expression of Panc02-OVA-Luc cell line

The protein expression of OVA in the wild-type Panc02 and Panc02-OVA-Luc cells were measured by Western Blot.

image.png

Figure 1. OVA expression in wild-type Panc02 and Panc02-OVA-Luc cell lines

Luciferase activity expression on the Panc02-OVA-Luc cell was measured by microplate reader.

image.png

Figure 2. Luciferase activity assay of Panc02-OVA-Luc cell line

Ⅱ.Characterization of in vivo growth kinetics

To verify whether there is the difference in tumor formation between the Panc02 -OVA-Luc cell line and the wild-type Panc02 cell line, both cells were subcutaneously inoculated into C57BL/6 mice.

image.png

Figure 3. Tumor growth curve of Panc02 and Panc02-OVA-Luc syngeneic model

image.png

Figure 4. Body weight change of Panc02 and Panc02-OVA-Luc syngeneic model

Ⅲ.Expression of OVA protein in tumors

image.png

Figure 5. The expression of OVA in tumors by Western Blot




You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more